Stephen Harding

Quantitative Assessment of Serum and Urinary Polyclonal Free Light Chains in Patients with Chronic Kidney Disease

Colin A. Hutchison, Stephen Harding, Pete Hewins et al. · Clinical Journal of the American Society of Nephrology · 2008 · 363 citations · Full text

Medicine, Nephrology, Pathology +17

Treatment of Acute Renal Failure Secondary to Multiple Myeloma with Chemotherapy and Extended High Cut-Off Hemodialysis

Colin A. Hutchison, A.R. Bradwell, Mark Cook et al. · Clinical Journal of the American Society of Nephrology · 2009 · 253 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure

Colin A. Hutchison, Tim Plant, Mark T. Drayson et al. · BMC Nephrology · 2008 · 208 citations · Full text

Medicine, Hematology, Nephrology +16

Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

Sæmundur Rögnvaldsson, Þorvarður Jón Löve, Sigrún Þorsteinsdóttir et al. · Blood Cancer Journal · 2021 · 119 citations · Full text

Medicine, Internal Medicine, Oncology +13

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

Þórir Einarsson Long, Ólafur S. Indridason, Runólfur Pálsson et al. · Blood Cancer Journal · 2022 · 117 citations · Full text

Medicine, Nephrology, Renal Pathology +16